Press Release: Sanofi announces decision not to submit amlitelimab in atopic dermatitis for global regulatory reviews
Sanofi announces decision not to submit amlitelimab in atopic dermatitis for global regulatory reviews Paris, July 24, 2026. Sanofi today...